The Role of Social Movements in Reducing Harmful Corporate Practices; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis”

Document Type : Commentary

Author

School of Public Health, City University of New York, New York City, NY, USA

Abstract

Systematic public monitoring of the practices of corporations that harm health is a necessary but not sufficient measure to reduce the adverse impact of these practices. By supporting social movements and health activist campaigns that seek to modify the corporate structures, systems and practices that harm health, public health professionals and researchers can bring powerful new voices into this crucial public health task. Partnerships between the public health organizations and social movements and activists who seek to make human and planetary well-being more important objectives than higher corporate profits can help to achieve this aim. Public health professionals can play an important role in supporting such partnerships. 

Keywords

References

  1. Bennett E, Topp SM, Moodie AR. National Public Health Surveillance of Corporations in key unhealthy commodity industries - a scoping review and framework synthesis. Int J Health Policy Manag. 2023;12:6876. doi:34172/ijhpm.2023.6876
  2. Lee K, Freudenberg N, Zenone M, et al. Measuring the commercial determinants of health and disease: a proposed framework. Int J Health Serv. 2022;52(1):115-128. doi:1177/00207314211044992
  3. Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023;401(10383):1194-1213. doi:1016/s0140-6736(23)00013-2
  4. Friel S, Collin J, Daube M, et al. Commercial determinants of health: future directions. Lancet. 2023;401(10383):1229-1240. doi:1016/s0140-6736(23)00011-9
  5. Duffy K, Harbath K. Defending the Year of Democracy: What it Will Take to Protect 2024’s 80-Plus Elections from Hostile Actors. Foreign Affairs. January 4, 2024. https://www.scribd.com/document/711106002/Defending-the-Year-of-Democracy.
  6. Mialon M, Bertscher A, Bero L, Vandevijvere S. Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy. HRB Open Res. 2022;5:41. doi:12688/hrbopenres.13553.2
  7. Lencucha R, Kothari A, Labonté R. The role of non-governmental organizations in global health diplomacy: negotiating the Framework Convention on Tobacco Control. Health Policy Plan. 2011;26(5):405-412. doi:1093/heapol/czq072
  8. Geiger S. Healthcare Activism, Marketization, and the Collective Good. Oxford, UK: Oxford University Press; 2021.
  9. Johnson DA, Duckett LJ. Advocacy, strategy and tactics used to confront corporate power: the Nestlé boycott and international code of marketing of breast-milk substitutes. J Hum Lact. 2020;36(4):568-578. doi:1177/0890334420955158
  10. Oreskes N, Conway EM. Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming. Bloomsbury Publishing USA; 2011.
  11. Mahood G. Tobacco Industry Denormalization: Telling the Truth About the Tobacco Industry’s Role in the Tobacco Epidemic. Ottawa: Non-Smokers’ Rights Association; 2004.
  12. Palmedo PC, Dorfman L, Garza S, Murphy E, Freudenberg N. Countermarketing alcohol and unhealthy food: an effective strategy for preventing noncommunicable diseases? Lessons from tobacco. Annu Rev Public Health. 2017;38:119-144. doi:1146/annurev-publhealth-031816-044303
  13. Parker LA, Zaragoza GA, Hernández-Aguado I. Promoting population health with public-private partnerships: where's the evidence? BMC Public Health. 2019;19(1):1438. doi:1186/s12889-019-7765-2
  14. Musolino C, Baum F, Freeman T, Labonté R, Bodini C, Sanders D. Global health activists' lessons on building social movements for Health for All. Int J Equity Health. 2020;19(1):116. doi:1186/s12939-020-01232-1
  15. Friel S. Redressing the corporate cultivation of consumption: releasing the weapons of the structurally weak. Int J Health Policy Manag. 2021;10(12):784-792. doi:34172/ijhpm.2020.205

Files

History

  • Receive Date: 19 June 2024
  • Revise Date: 18 October 2024
  • Accept Date: 20 October 2024
  • First Publish Date: 22 October 2024

Share

How to cite

Statistics